Benign Prostatic Hyperplasia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
Condition: Benign Prostatic Hyperplasia Intervention: Device: HIFU treatment Sponsor: EDAP TMS S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2021 Category: Research Source Type: clinical trials
REZ ŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
Condition: Benign Prostatic Hyperplasia (BPH) Interventions: Device: REZŪM; Drug: alpha blocker and 5-alpha reductase inhibitor Sponsor: Boston Scientific Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2021 Category: Research Source Type: clinical trials
